Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00182) | |||||
---|---|---|---|---|---|
Name |
Desvenlafaxine
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
Desvenlafaxine; 93413-62-8; O-Desmethylvenlafaxine; 4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol; 4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol; O-desmethyl venlafaxine; O-Desvenlafaxine; d,l-O-Desmethylvenlafaxine; CHEBI:83527; 93413-62-8 (free base); Desvenlafaxine, 97%; 1-[2-(dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol; Phenol, 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)-; Phenol, 4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]-; Desvenlafaxine [INN:BAN]; Khedezla; Desvenlafaxine (INN); Venlafaxine O-Desmethyl; HSDB 7993; Khedezla (TN); O-DESMETHYLVENLAFAXINE (ODV); O-desmethyl-venlafaxine; ACMC-20ek0k; EC 700-516-2; CHEMBL1118; SCHEMBL34864; MLS006010042; O-Desmethylvenlafaxine solution; (S)-Desmethyl Venlafaxine D6; GTPL7158; 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol; BDBM86748; DTXSID40869118; HMS3652K16; HMS3885F05; BCP28517; HY-B0602; MFCD00871934; PDSP1_001804; PDSP2_001787; AKOS015896311; CCG-267081; DB06700; DS-1282; SB17444; NSC_6918664; NCGC00345883-04; NCGC00345883-07; AK-72949; AT-19352; BR-72949; SMR004701214; O-Desmethylvenlafaxine, analytical standard; AB0031560; CAS_386750-22-7; FT-0654519; FT-0666245; FT-0666246; SW219514-2; O-Desmethylvenlafaxine 0.1 mg/ml in Methanol; D07793; J10126; S-2830; AB01563022_01; 413D628; A844583; Q2419445; Venlafaxine O-desmethyl 100 microg/mL in Acetonitrile; 4-[2-Dimethyamino-1-(1-hydroxycyclohexyl)ethyl]phenol; 1-[2-dimethylamino-1-(4-hydroxyphenyl)ethyl]cyclohexanol; 4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)-ethyl)phenol; 4-[2-(dimethylamino)-1-(1-oxidanylcyclohexyl)ethyl]phenol; 4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol #; (RS)-1-[2-(dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol; O-Desmethylvenlafaxine solution, 1.0 mg/mL in methanol, certified reference material; O-Desmethylvenlafaxine solution, 100 mug/mL in methanol, ampule of 1 mL, certified reference material
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Major depressive disorder | ICD-11: 6A70 | [1] | ||
PubChem CID | |||||
Formula |
C16H25NO2
|
||||
Canonical SMILES |
CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
|
||||
InChI |
1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3
|
||||
InChIKey |
KYYIDSXMWOZKMP-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=125017"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 263.37 | Topological Polar Surface Area | 43.7 | |
XlogP | 2.6 | Complexity | 266 | ||
Heavy Atom Count | 19 | Rotatable Bond Count | 4 | ||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Desvenlafaxine 100 mg tablet | Click to Show/Hide the Full List of Formulation(s): 5 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c yellow no. 6; Magnesium stearate; Citric acid monohydrate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Hypromellose 2208 (100000 mpa.s); Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c yellow no. 6; Magnesium stearate; Citric acid monohydrate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromellose 2208 (100000 mpa.s); Polyethylene glycols; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Macoven Pharmaceuticals; Pernix Therapeutics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butyl alcohol; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Polyvinyl alcohol; Cellulose, microcrystalline; Hypromellose 2208 (15000 mpa.s); Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Citric acid monohydrate; Ferric oxide red; Ferrosoferric oxide; Talc; Titanium dioxide; Povidone k30; Alginic acid; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycol 8000
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Desvenlafaxine 50 mg tablet | Click to Show/Hide the Full List of Formulation(s): 4 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butyl alcohol; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Citric acid monohydrate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Hypromellose 2208 (100000 mpa.s); Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Citric acid monohydrate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromellose 2208 (100000 mpa.s); Polyethylene glycols; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Macoven Pharmaceuticals; Pernix Therapeutics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Citric acid monohydrate; Ferric oxide red; Talc; Titanium dioxide; Polyethylene glycol 6000; Povidone k30; Alginic acid; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [5] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.